This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Anticompetitive practices in key sectors are enforcement targets for market regulator in China’s Guangxi

( February 23, 2023, 04:14 GMT | Official Statement) -- MLex Summary: Fixing prices, restricting production volumes and splitting sales territories in the building-materials, automobile and pharmaceutical industries will be targeted during a campaign launched recently by the Administration for Market Regulation of China’s Guangxi Zhuang Autonomous Region that will last until October this year. The Guangxi market regulator will also crack down on tying and imposing exclusivity requirements or unreasonable transaction terms by utility companies that supply water, heat, gas or electricity. Additionally, anticompetitive practices involving abuse of administrative power will also be enforcement targets for the regulator, with a focus on sectors such as education, transport, construction, insurance and government procurement.The statement follows:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections